Platelet transfusion thresholds in neonatal medicine

Area of Science:

• Neonatal Medicine
• Hematology
• Pediatric Critical Care

Background:

• Thrombocytopenia is a frequent complication in preterm neonates, necessitating careful management.
• Current guidelines for prophylactic platelet transfusions lack robust evidence, leading to wide variations in transfusion thresholds.
• Existing transfusion practices in neonates are often based on adult or trauma protocols, not specific neonatal physiology.

Purpose of the Study:

• To evaluate the safety and efficacy of different prophylactic platelet transfusion thresholds in preterm neonates.
• To investigate potential mechanisms of harm associated with platelet transfusions in this population.
• To highlight the need for evidence-based guidelines for neonatal platelet transfusions.

Main Methods:

• The study involved analyzing data from the PlaNet-2/MATISSE Study, comparing outcomes between different platelet count thresholds for transfusion.
• Review of existing literature on platelet transfusion practices, adverse events, and potential harm mechanisms in neonates.
• Examination of immunological, inflammatory, and blood group incompatibility factors in transfusion-associated adverse events.

Main Results:

• Prophylactic platelet transfusion below a threshold of 50 × 10^9/L was associated with increased mortality and major bleeding events compared to a threshold of 25 × 10^9/L.
• Neonatal platelet transfusion volumes and rates often exceed adult standards and do not account for preterm infant physiology.
• Classification of transfusion-associated adverse events in neonates presents significant challenges.

Conclusions:

• Higher platelet count thresholds (50 × 10^9/L) appear safer for prophylactic transfusions in preterm neonates than lower thresholds (25 × 10^9/L).
• Current neonatal platelet transfusion practices require significant revision to align with neonatal physiology and evidence-based medicine.
• Further research is crucial to better understand thrombocytopenia, platelet transfusion efficacy, and adverse effects in preterm infants.